Pub Date : 2020-10-13eCollection Date: 2020-01-01DOI: 10.1177/2235042X20961676
Frances S Mair, Hamish Me Foster, Barbara I Nicholl
{"title":"Multimorbidity and the COVID-19 pandemic - An urgent call to action.","authors":"Frances S Mair, Hamish Me Foster, Barbara I Nicholl","doi":"10.1177/2235042X20961676","DOIUrl":"10.1177/2235042X20961676","url":null,"abstract":"","PeriodicalId":92071,"journal":{"name":"Journal of comorbidity","volume":"10 ","pages":"2235042X20961676"},"PeriodicalIF":0.0,"publicationDate":"2020-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/71/d0/10.1177_2235042X20961676.PMC7573706.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38540140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-09-24eCollection Date: 2020-01-01DOI: 10.1177/2235042X20953313
Kathryn Nicholson, Tine De Burghgraeve, Martin Fortin, Lauren E Griffith, Silvan Licher, Daniel Lizotte, Frances S Mair, Ruben Miozzo, Maede Sadat Nouri, Bridget L Ryan, Eng Sing Lee, Susan Smith, Moira Stewart, Amanda L Terry, Mayra Tisminetzky, Maria Ukhanova, Stephen Wetmore, Saverio Stranges
The International Multimorbidity Symposium was held in November 2019 at Western University to achieve three main objectives: to discuss progress and findings from various jurisdictions; to facilitate collaboration through group discussion to identify strategies to move multimorbidity research forward; and to create concrete plans to ensure advances in multimorbidity research and knowledge can be achieved through cross-national partnership. This event included keynote presentations, elevator pitch presentations and breakout sessions and there was a total of 35 attendees from eight countries, representing diverse disciplines and training levels. The overall themes arising from the event were: the importance of integrating the study and management of multimorbidity from both the primary care and public health perspectives; meaningful engagement and collaboration with patients and caregivers to understand key dimensions of multimorbidity; the considerable benefit of collaborative international partnerships; and the need to spread and scale innovations for health care systems that can better respond to the complex needs of patients and caregivers who are living with multimorbidity. Finally, it was well-acknowledged among the attendees that expanding the collaboration and discussion among international colleagues via in-person and virtual events will be important to move multimorbidity research forward.
{"title":"Advancing cross-national planning and partnership: Proceedings from the International Multimorbidity Symposium 2019.","authors":"Kathryn Nicholson, Tine De Burghgraeve, Martin Fortin, Lauren E Griffith, Silvan Licher, Daniel Lizotte, Frances S Mair, Ruben Miozzo, Maede Sadat Nouri, Bridget L Ryan, Eng Sing Lee, Susan Smith, Moira Stewart, Amanda L Terry, Mayra Tisminetzky, Maria Ukhanova, Stephen Wetmore, Saverio Stranges","doi":"10.1177/2235042X20953313","DOIUrl":"https://doi.org/10.1177/2235042X20953313","url":null,"abstract":"<p><p>The International Multimorbidity Symposium was held in November 2019 at Western University to achieve three main objectives: to discuss progress and findings from various jurisdictions; to facilitate collaboration through group discussion to identify strategies to move multimorbidity research forward; and to create concrete plans to ensure advances in multimorbidity research and knowledge can be achieved through cross-national partnership. This event included keynote presentations, elevator pitch presentations and breakout sessions and there was a total of 35 attendees from eight countries, representing diverse disciplines and training levels. The overall themes arising from the event were: the importance of integrating the study and management of multimorbidity from both the primary care and public health perspectives; meaningful engagement and collaboration with patients and caregivers to understand key dimensions of multimorbidity; the considerable benefit of collaborative international partnerships; and the need to spread and scale innovations for health care systems that can better respond to the complex needs of patients and caregivers who are living with multimorbidity. Finally, it was well-acknowledged among the attendees that expanding the collaboration and discussion among international colleagues via in-person and virtual events will be important to move multimorbidity research forward.</p>","PeriodicalId":92071,"journal":{"name":"Journal of comorbidity","volume":"10 ","pages":"2235042X20953313"},"PeriodicalIF":0.0,"publicationDate":"2020-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/2235042X20953313","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38469118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-09-14eCollection Date: 2020-01-01DOI: 10.1177/2235042X20946243
Caroline McCarthy, Frank Moriarty, Emma Wallace, Susan M Smith
Introduction: By the time an intervention is ready for evaluation in a definitive RCT the context of the evidence base may have evolved. To avoid research waste, it is imperative that intervention design and evaluation is an adaptive process incorporating emerging evidence and novel concepts. The aim of this study is to describe changes that were made to an evidence based intervention at the protocol stage of the definitive RCT to incorporate emerging evidence. Methods: The original evidence based intervention, a GP delivered web guided medication review, was modified in a five step process: Identification of core components of the original intervention. Literature review. Modification of the intervention. Pilot study. Final refinements. A framework, developed in public health research, was utilised to describe the modification process. Results: The population under investigation changed from older people with a potentially inappropriate prescription (PIP) to older people with significant polypharmacy, a proxy marker for complex multimorbidity. An assessment of treatment priorities and brown bag medication review, with a focus on deprescribing were incorporated into the original intervention. The number of repeat medicines was added as a primary outcome measure as were additional secondary patient reported outcome measures to assess treatment burden and attitudes towards deprescribing. Conclusions: A framework was used to systematically describe how and why the original intervention was modified, allowing the new intervention to build upon an effective and robustly developed intervention but also to be relevant in the context of the current evidence base.
{"title":"The evolution of an evidence based intervention designed to improve prescribing and reduce polypharmacy in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE).","authors":"Caroline McCarthy, Frank Moriarty, Emma Wallace, Susan M Smith","doi":"10.1177/2235042X20946243","DOIUrl":"https://doi.org/10.1177/2235042X20946243","url":null,"abstract":"Introduction: By the time an intervention is ready for evaluation in a definitive RCT the context of the evidence base may have evolved. To avoid research waste, it is imperative that intervention design and evaluation is an adaptive process incorporating emerging evidence and novel concepts. The aim of this study is to describe changes that were made to an evidence based intervention at the protocol stage of the definitive RCT to incorporate emerging evidence. Methods: The original evidence based intervention, a GP delivered web guided medication review, was modified in a five step process: Identification of core components of the original intervention. Literature review. Modification of the intervention. Pilot study. Final refinements. A framework, developed in public health research, was utilised to describe the modification process. Results: The population under investigation changed from older people with a potentially inappropriate prescription (PIP) to older people with significant polypharmacy, a proxy marker for complex multimorbidity. An assessment of treatment priorities and brown bag medication review, with a focus on deprescribing were incorporated into the original intervention. The number of repeat medicines was added as a primary outcome measure as were additional secondary patient reported outcome measures to assess treatment burden and attitudes towards deprescribing. Conclusions: A framework was used to systematically describe how and why the original intervention was modified, allowing the new intervention to build upon an effective and robustly developed intervention but also to be relevant in the context of the current evidence base.","PeriodicalId":92071,"journal":{"name":"Journal of comorbidity","volume":"10 ","pages":"2235042X20946243"},"PeriodicalIF":0.0,"publicationDate":"2020-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/2235042X20946243","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38417327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-08-27eCollection Date: 2020-01-01DOI: 10.1177/2235042X20950598
B L Ryan, B Allen, M Zwarenstein, M Stewart, R H Glazier, M Fortin, S J Wetmore, S Z Shariff
Objective: To examine the relationship between multimorbidity and mortality, and whether relationship varied by material deprivation/rural location and by age.
Methods: Retrospective population-based cohort study conducted using 2013-14 data from previously created cohort of Ontario, Canada residents classified according to whether or not they had multimorbidity, defined as having 3+ of 17 chronic conditions. Adjusted rate ratios were calculated to compare mortality rates for those with and without multimorbidity, comparing rates by material deprivation/rural location, and by age group.
Results: There were 13,581,191 people in the cohort ages 0 to 105 years; 15.2% had multimorbidity. Median length of observation was 365 days. Adjusted mortality rate ratios did not vary by material deprivation/rural location; overall adjusted mortality rate ratio was 2.41 (95% CI 2.37-2.45). Adjusted mortality rate ratios varied by age with ratios decreasing as age increased. Overall rate ratio was 14.7 (95% CI 14.48-14.91). Children (0-17 years) had highest ratio, 40.06 (95% CI 26.21-61.22). Youngest adult age group (18-24 years) had rate ratio of 9.96 (95% CI 7.18-13.84); oldest age group (80+ years) had rate ratio of 1.97 (95% CI 1.94-2.04).
Conclusion: Compared to people without multimorbidity, multimorbidity conferred higher risk of death in this study at all age groups. Risk was greater in early and middle adulthood than in older ages. Results reinforce the fact multimorbidity is not just a problem of aging, and multimorbidity leads not only to poorer health and higher health care utilization, but also to a higher risk of death at a younger age.
目的:探讨多发病与死亡率之间的关系,以及这种关系是否因物质匮乏/农村地区和年龄而异。方法:基于人群的回顾性队列研究,使用2013-14年之前创建的加拿大安大略省居民队列的数据,根据他们是否患有多重疾病进行分类,定义为患有17种慢性疾病中的3种以上。计算调整后的死亡率比率,以比较有和没有多重疾病的人的死亡率,按物质匮乏/农村地区和按年龄组比较死亡率。结果:0 ~ 105岁的队列中有13581191人;15.2%为多病。中位观察时间为365天。调整后的死亡率不因物质匮乏/农村地区而异;总调整死亡率比为2.41 (95% CI 2.37-2.45)。调整后的死亡率比率因年龄而异,随着年龄的增加而降低。总发病率比为14.7 (95% CI 14.48-14.91)。0 ~ 17岁儿童的比例最高,为40.06 (95% CI 26.21 ~ 61.22)。最年轻年龄组(18-24岁)发病率比为9.96 (95% CI 7.18-13.84);最高龄组(80岁以上)发病率比为1.97 (95% CI 1.94 ~ 2.04)。结论:与没有多重发病的人相比,本研究中所有年龄组的多重发病患者的死亡风险更高。成年早期和中期的风险高于老年。结果表明,多病不仅仅是一个老龄化问题,而且多病不仅会导致健康状况恶化和医疗保健利用率提高,而且还会增加年轻时死亡的风险。
{"title":"Multimorbidity and mortality in Ontario, Canada: A population-based retrospective cohort study.","authors":"B L Ryan, B Allen, M Zwarenstein, M Stewart, R H Glazier, M Fortin, S J Wetmore, S Z Shariff","doi":"10.1177/2235042X20950598","DOIUrl":"https://doi.org/10.1177/2235042X20950598","url":null,"abstract":"<p><strong>Objective: </strong>To examine the relationship between multimorbidity and mortality, and whether relationship varied by material deprivation/rural location and by age.</p><p><strong>Methods: </strong>Retrospective population-based cohort study conducted using 2013-14 data from previously created cohort of Ontario, Canada residents classified according to whether or not they had multimorbidity, defined as having 3+ of 17 chronic conditions. Adjusted rate ratios were calculated to compare mortality rates for those with and without multimorbidity, comparing rates by material deprivation/rural location, and by age group.</p><p><strong>Results: </strong>There were 13,581,191 people in the cohort ages 0 to 105 years; 15.2% had multimorbidity. Median length of observation was 365 days. Adjusted mortality rate ratios did not vary by material deprivation/rural location; overall adjusted mortality rate ratio was 2.41 (95% CI 2.37-2.45). Adjusted mortality rate ratios varied by age with ratios decreasing as age increased. Overall rate ratio was 14.7 (95% CI 14.48-14.91). Children (0-17 years) had highest ratio, 40.06 (95% CI 26.21-61.22). Youngest adult age group (18-24 years) had rate ratio of 9.96 (95% CI 7.18-13.84); oldest age group (80+ years) had rate ratio of 1.97 (95% CI 1.94-2.04).</p><p><strong>Conclusion: </strong>Compared to people without multimorbidity, multimorbidity conferred higher risk of death in this study at all age groups. Risk was greater in early and middle adulthood than in older ages. Results reinforce the fact multimorbidity is not just a problem of aging, and multimorbidity leads not only to poorer health and higher health care utilization, but also to a higher risk of death at a younger age.</p>","PeriodicalId":92071,"journal":{"name":"Journal of comorbidity","volume":"10 ","pages":"2235042X20950598"},"PeriodicalIF":0.0,"publicationDate":"2020-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/2235042X20950598","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38473976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-07-31eCollection Date: 2020-01-01DOI: 10.1177/2235042X10944344
Peter Hanlon, Marianne McCallum, Bhautesh Dinesh Jani, Ross McQueenie, Duncan Lee, Frances S Mair
Background: Child maltreatment is associated with long-term conditions (LTCs) in adulthood. Its relationship to multimorbidity (≥2 LTCs) is less clear. We explore the relationship between child maltreatment, multimorbidity and factors complicating management.
Methods: Cross-sectional analysis of 157,357 UK Biobank participants. Experience of four maltreatment types (physical/sexual/emotional/neglect) was identified. We explored the relationship between type, number and frequency of maltreatment and LTC count (0, 1, 2, 3, ≥4) using multinomial logistic regression. Binary logistic regression assessed the relationship between maltreatment and self-rated health, loneliness, social isolation, frailty and widespread pain in those with multimorbidity, adjusting for sociodemographics and lifestyle factors.
Results: 52,675 participants (33%) experienced ≥1 type of maltreatment; 983 (0.6%) experienced all four. Type, frequency and number of types of maltreatment were associated with higher LTC count. People experiencing four types of maltreatment were 5 times as likely to have a LTC count of ≥4 as those experiencing none (odds ratio (OR): 5.16; 99% confidence interval (CI): 3.77-7.07). Greater number of types of maltreatment was associated with higher prevalence of combined physical/mental health LTCs (OR: 2.99; 99% CI: 2.54-3.51 for four types of maltreatment). Compared to people who reported no maltreatment, people experiencing all four types of maltreatment were more likely to have poor self-rated health (OR: 3.56; 99% CI: 2.58-4.90), loneliness (OR: 3.16; 99% CI: 2.17-4.60), social isolation (OR: 1.45; 99% CI: 1.03-2.05), widespread pain (OR: 3.19; 99% CI: 1.87-5.44) and frailty (OR: 3.21; 99% CI: 2.04-5.05).
Conclusion: Peoplewith a history of maltreatment have higher LTC counts and potentially more complicated management needs reinforcing calls for early intervention.
{"title":"Association between childhood maltreatment and the prevalence and complexity of multimorbidity: A cross-sectional analysis of 157,357 UK Biobank participants.","authors":"Peter Hanlon, Marianne McCallum, Bhautesh Dinesh Jani, Ross McQueenie, Duncan Lee, Frances S Mair","doi":"10.1177/2235042X10944344","DOIUrl":"https://doi.org/10.1177/2235042X10944344","url":null,"abstract":"<p><strong>Background: </strong>Child maltreatment is associated with long-term conditions (LTCs) in adulthood. Its relationship to multimorbidity (≥2 LTCs) is less clear. We explore the relationship between child maltreatment, multimorbidity and factors complicating management.</p><p><strong>Methods: </strong>Cross-sectional analysis of 157,357 UK Biobank participants. Experience of four maltreatment types (physical/sexual/emotional/neglect) was identified. We explored the relationship between type, number and frequency of maltreatment and LTC count (0, 1, 2, 3, ≥4) using multinomial logistic regression. Binary logistic regression assessed the relationship between maltreatment and self-rated health, loneliness, social isolation, frailty and widespread pain in those with multimorbidity, adjusting for sociodemographics and lifestyle factors.</p><p><strong>Results: </strong>52,675 participants (33%) experienced ≥1 type of maltreatment; 983 (0.6%) experienced all four. Type, frequency and number of types of maltreatment were associated with higher LTC count. People experiencing four types of maltreatment were 5 times as likely to have a LTC count of ≥4 as those experiencing none (odds ratio (OR): 5.16; 99% confidence interval (CI): 3.77-7.07). Greater number of types of maltreatment was associated with higher prevalence of combined physical/mental health LTCs (OR: 2.99; 99% CI: 2.54-3.51 for four types of maltreatment). Compared to people who reported no maltreatment, people experiencing all four types of maltreatment were more likely to have poor self-rated health (OR: 3.56; 99% CI: 2.58-4.90), loneliness (OR: 3.16; 99% CI: 2.17-4.60), social isolation (OR: 1.45; 99% CI: 1.03-2.05), widespread pain (OR: 3.19; 99% CI: 1.87-5.44) and frailty (OR: 3.21; 99% CI: 2.04-5.05).</p><p><strong>Conclusion: </strong>Peoplewith a history of maltreatment have higher LTC counts and potentially more complicated management needs reinforcing calls for early intervention.</p>","PeriodicalId":92071,"journal":{"name":"Journal of comorbidity","volume":"10 ","pages":"2235042X10944344"},"PeriodicalIF":0.0,"publicationDate":"2020-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/2235042X10944344","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38308249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-07-30eCollection Date: 2020-01-01DOI: 10.1177/2235042X20935312
Hanne Birke, Ramune Jacobsen, Alexandra Br Jønsson, Ann Dorrit Kristiane Guassora, Marie Walther, Thomas Saxild, Jannie T Laursen, Maria Helena Dominquez Vall-Lamora, Anne Frølich
Aim: To assess the feasibility of a patient-centered complex intervention for multimorbidity (CIM) based on general practice in collaboration with community health-care centers and outpatient clinics.
Methods: Inclusion criteria were age ≥18 years, diagnoses of two or more of three chronic conditions (diabetes, chronic obstructive pulmonary disease (COPD), and chronic heart conditions), and a hospital contact during the previous year. The CIM included extended consultations and nurse care manager support in general practice and intensified cross-sectorial collaboration. Elements included a structured care plan based on patients' care goals, coordination of services, and, if appropriate, shifting outpatient clinic visits to general practice, medication review, referral to rehabilitation, and home care. The acceptability dimension of feasibility was assessed with validated questionnaires, observations, and focus groups.
Results: Forty-eight patients were included (mean age 72.2 (standard deviation (SD) 9.5, range 52-89); 23 (48%) were men. Thirty-seven patients had two diseases; most commonly COPD and cardiovascular disease (46%), followed by diabetes and cardiovascular disease (23%), and COPD and diabetes (15%). Eleven (23%) patients had all three conditions. Focus group interviews with patients with multimorbidity identified three main themes: (1) lack of care coordination existed across health-care sectors before the CIM, (2) extended consultations provided better care coordination, and (3) patients want to be involved in planning their treatment and care. In focus groups, health-care professionals discussed two main themes: (1) patient-centered care and (2) culture and organizational change. Completion rates for questionnaires were 98% (47/48).
Conclusions: Patients and health-care professionals found the CIM acceptable.
{"title":"A complex intervention for multimorbidity in primary care: A feasibility study.","authors":"Hanne Birke, Ramune Jacobsen, Alexandra Br Jønsson, Ann Dorrit Kristiane Guassora, Marie Walther, Thomas Saxild, Jannie T Laursen, Maria Helena Dominquez Vall-Lamora, Anne Frølich","doi":"10.1177/2235042X20935312","DOIUrl":"https://doi.org/10.1177/2235042X20935312","url":null,"abstract":"<p><strong>Aim: </strong>To assess the feasibility of a patient-centered complex intervention for multimorbidity (CIM) based on general practice in collaboration with community health-care centers and outpatient clinics.</p><p><strong>Methods: </strong>Inclusion criteria were age ≥18 years, diagnoses of two or more of three chronic conditions (diabetes, chronic obstructive pulmonary disease (COPD), and chronic heart conditions), and a hospital contact during the previous year. The CIM included extended consultations and nurse care manager support in general practice and intensified cross-sectorial collaboration. Elements included a structured care plan based on patients' care goals, coordination of services, and, if appropriate, shifting outpatient clinic visits to general practice, medication review, referral to rehabilitation, and home care. The acceptability dimension of feasibility was assessed with validated questionnaires, observations, and focus groups.</p><p><strong>Results: </strong>Forty-eight patients were included (mean age 72.2 (standard deviation (SD) 9.5, range 52-89); 23 (48%) were men. Thirty-seven patients had two diseases; most commonly COPD and cardiovascular disease (46%), followed by diabetes and cardiovascular disease (23%), and COPD and diabetes (15%). Eleven (23%) patients had all three conditions. Focus group interviews with patients with multimorbidity identified three main themes: (1) lack of care coordination existed across health-care sectors before the CIM, (2) extended consultations provided better care coordination, and (3) patients want to be involved in planning their treatment and care. In focus groups, health-care professionals discussed two main themes: (1) patient-centered care and (2) culture and organizational change. Completion rates for questionnaires were 98% (47/48).</p><p><strong>Conclusions: </strong>Patients and health-care professionals found the CIM acceptable.</p>","PeriodicalId":92071,"journal":{"name":"Journal of comorbidity","volume":"10 ","pages":"2235042X20935312"},"PeriodicalIF":0.0,"publicationDate":"2020-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/2235042X20935312","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38308250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-07-16eCollection Date: 2020-01-01DOI: 10.1177/2235042X20940493
Heather E Whitson, Alexandra M Hajduk, Xuemei Song, Mary Geda, Sui Tsang, John Brush, Sarwat I Chaudhry
Older patients presenting with acute myocardial infarction (AMI) often have comorbidities. Our objective was to examine how outcomes differ by cognitive and vision status in older AMI patients. We use data from a prospective cohort study conducted at 94 hospitals in the United States between January 2013 and October 2016 that enrolled men and women aged ≥75 years with AMI. Cognitive impairment (CI) was defined as telephone interview for cognitive status (TICS) score <27; vision impairment (VI) and activities of daily living (ADLs) were assessed by questionnaire. Of 2988 senior AMI patients, 260 (8.7%) had CI but no VI, 858 (28.7%) had VI but no CI, and 251 (8.4%) had both CI/VI. Patients in the VI/CI group were most likely to exhibit geriatric syndromes. More severe VI was associated with lower (worse) scores on the TICS (β -1.53, 95% confidence interval (CI) -1.87 to -1.18). In adjusted models, compared to participants with neither impairment, participants with VI/CI were more likely to die (hazard ratio 1.61, 95% CI 1.10-2.37) and experience ADL decline (odds ratio 2.11, 95% CI 1.39-3.21) at 180 days. Comorbid CIs and VIs were associated with high rates of death and worsening disability after discharge among seniors hospitalized for AMI. Future research should evaluate protocols to accommodate these impairments during AMI presentations and optimize decision-making and outcomes.
老年急性心肌梗死(AMI)患者常伴有合并症。我们的目的是研究老年AMI患者的认知和视力状况对预后的影响。我们使用的数据来自2013年1月至2016年10月期间在美国94家医院进行的前瞻性队列研究,纳入了年龄≥75岁的AMI患者。认知障碍(CI)定义为电话访谈的认知状态(TICS)评分β -1.53, 95%可信区间(CI) -1.87 ~ -1.18。在调整后的模型中,与没有损伤的参与者相比,有VI/CI的参与者更有可能在180天死亡(风险比1.61,95% CI 1.10-2.37),并且经历ADL下降(优势比2.11,95% CI 1.39-3.21)。在AMI住院的老年人中,合并症CIs和VIs与高死亡率和出院后残疾恶化有关。未来的研究应该评估在AMI表现期间适应这些损伤的方案,并优化决策和结果。
{"title":"Comorbid vision and cognitive impairments in older adults hospitalized for acute myocardial infarction.","authors":"Heather E Whitson, Alexandra M Hajduk, Xuemei Song, Mary Geda, Sui Tsang, John Brush, Sarwat I Chaudhry","doi":"10.1177/2235042X20940493","DOIUrl":"https://doi.org/10.1177/2235042X20940493","url":null,"abstract":"<p><p>Older patients presenting with acute myocardial infarction (AMI) often have comorbidities. Our objective was to examine how outcomes differ by cognitive and vision status in older AMI patients. We use data from a prospective cohort study conducted at 94 hospitals in the United States between January 2013 and October 2016 that enrolled men and women aged ≥75 years with AMI. Cognitive impairment (CI) was defined as telephone interview for cognitive status (TICS) score <27; vision impairment (VI) and activities of daily living (ADLs) were assessed by questionnaire. Of 2988 senior AMI patients, 260 (8.7%) had CI but no VI, 858 (28.7%) had VI but no CI, and 251 (8.4%) had both CI/VI. Patients in the VI/CI group were most likely to exhibit geriatric syndromes. More severe VI was associated with lower (worse) scores on the TICS (<i>β</i> -1.53, 95% confidence interval (CI) -1.87 to -1.18). In adjusted models, compared to participants with neither impairment, participants with VI/CI were more likely to die (hazard ratio 1.61, 95% CI 1.10-2.37) and experience ADL decline (odds ratio 2.11, 95% CI 1.39-3.21) at 180 days. Comorbid CIs and VIs were associated with high rates of death and worsening disability after discharge among seniors hospitalized for AMI. Future research should evaluate protocols to accommodate these impairments during AMI presentations and optimize decision-making and outcomes.</p>","PeriodicalId":92071,"journal":{"name":"Journal of comorbidity","volume":"10 ","pages":"2235042X20940493"},"PeriodicalIF":0.0,"publicationDate":"2020-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/2235042X20940493","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38206300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-06-26eCollection Date: 2020-01-01DOI: 10.1177/2235042X20931287
Lauren E Griffith, Andrea Gruneir, Kathryn A Fisher, Ross Upshur, Christopher Patterson, Richard Perez, Lindsay Favotto, Maureen Markle-Reid, Jenny Ploeg
Objective: To examine agreement between administrative and self-reported data on the number of and constituent chronic conditions (CCs) used to measure multimorbidity.
Study design and setting: Cross-sectional self-reported survey data from four Canadian Community Health Survey waves were linked to administrative data for residents of Ontario, Canada. Agreement for each of 12 CCs was assessed using kappa (κ) statistics. For the overall number of CCs, perfect agreement was defined as agreement on both the number and constituent CCs. Jackknife methods were used to assess the impact of individual CCs on perfect agreement.
Results: The level of chance-adjusted agreement between self-report and administrative data for individual CCs varied widely, from κ = 5.5% (inflammatory bowel disease) to κ = 77.5% (diabetes), and there was no clear pattern on whether using administrative data or self-reported data led to higher prevalence estimates. Only 26.9% of participants had perfect agreement on the number and constituent CCs; 10.6% agreed on the number but not constituent CCs. The impact of each CC on perfect agreement depended on both the level of agreement and the prevalence of the individual CC.
Conclusion: Our results show that measuring agreement on multimorbidity is more complex than for individual CCs and that even small levels of individual condition disagreement can have a large impact on the agreement on the number of CCs.
{"title":"The hidden complexity of measuring number of chronic conditions using administrative and self-report data: A short report.","authors":"Lauren E Griffith, Andrea Gruneir, Kathryn A Fisher, Ross Upshur, Christopher Patterson, Richard Perez, Lindsay Favotto, Maureen Markle-Reid, Jenny Ploeg","doi":"10.1177/2235042X20931287","DOIUrl":"10.1177/2235042X20931287","url":null,"abstract":"<p><strong>Objective: </strong>To examine agreement between administrative and self-reported data on the number of and constituent chronic conditions (CCs) used to measure multimorbidity.</p><p><strong>Study design and setting: </strong>Cross-sectional self-reported survey data from four Canadian Community Health Survey waves were linked to administrative data for residents of Ontario, Canada. Agreement for each of 12 CCs was assessed using kappa (<i>κ</i>) statistics. For the overall number of CCs, perfect agreement was defined as agreement on both the number and constituent CCs. Jackknife methods were used to assess the impact of individual CCs on perfect agreement.</p><p><strong>Results: </strong>The level of chance-adjusted agreement between self-report and administrative data for individual CCs varied widely, from <i>κ</i> = 5.5% (inflammatory bowel disease) to <i>κ</i> = 77.5% (diabetes), and there was no clear pattern on whether using administrative data or self-reported data led to higher prevalence estimates. Only 26.9% of participants had perfect agreement on the number and constituent CCs; 10.6% agreed on the number but not constituent CCs. The impact of each CC on perfect agreement depended on both the level of agreement and the prevalence of the individual CC.</p><p><strong>Conclusion: </strong>Our results show that measuring agreement on multimorbidity is more complex than for individual CCs and that even small levels of individual condition disagreement can have a large impact on the agreement on the number of CCs.</p>","PeriodicalId":92071,"journal":{"name":"Journal of comorbidity","volume":"10 ","pages":"2235042X20931287"},"PeriodicalIF":0.0,"publicationDate":"2020-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/2235042X20931287","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38131256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-06-18eCollection Date: 2020-01-01DOI: 10.1177/2235042X20924172
Husayn Marani, Hayley Baranek, Howard Abrams, Michael McDonald, Megan Nguyen, Juan Duero Posada, Heather Ross, Toni Schofield, James Shaw, R Sacha Bhatia
Background: Heart failure patients often present with frailty and/or multi-morbidity, complicating care and service delivery. The Chronic Care Model (CCM) is a useful framework for designing care for complex patients. It assumes responsibility of several actors, including frontline providers and health-care administrators, in creating conditions for optimal chronic care management. This qualitative case study examines perceptions of care among providers and administrators in a large, urban health system in Canada, and how the CCM might inform redesign of care to improve health system functioning.
Methods: Sixteen semi-structured interviews were conducted between August 2014 and January 2016. Interpretive analysis was conducted to identify how informants perceive care among this population and the extent to which the design of heart failure care aligns with elements of the CCM.
Results: Current care approaches could better align with CCM elements. Key changes to improve health system functioning for complex heart failure patients that align with the CCM include closing knowledge gaps, standardizing treatment, improving interdisciplinary communication and improving patient care pathways following hospital discharge.
Conclusions: The CCM can be used to guide health system design and interventions for frail and multi-morbid heart failure patients. Addressing care- and service-delivery barriers has important clinical, administrative and economic implications.
{"title":"Improving the design of heart failure care from the perspective of frontline providers and administrators: A qualitative case study of a large, urban health system.","authors":"Husayn Marani, Hayley Baranek, Howard Abrams, Michael McDonald, Megan Nguyen, Juan Duero Posada, Heather Ross, Toni Schofield, James Shaw, R Sacha Bhatia","doi":"10.1177/2235042X20924172","DOIUrl":"10.1177/2235042X20924172","url":null,"abstract":"<p><strong>Background: </strong>Heart failure patients often present with frailty and/or multi-morbidity, complicating care and service delivery. The Chronic Care Model (CCM) is a useful framework for designing care for complex patients. It assumes responsibility of several actors, including frontline providers and health-care administrators, in creating conditions for optimal chronic care management. This qualitative case study examines perceptions of care among providers and administrators in a large, urban health system in Canada, and how the CCM might inform redesign of care to improve health system functioning.</p><p><strong>Methods: </strong>Sixteen semi-structured interviews were conducted between August 2014 and January 2016. Interpretive analysis was conducted to identify how informants perceive care among this population and the extent to which the design of heart failure care aligns with elements of the CCM.</p><p><strong>Results: </strong>Current care approaches could better align with CCM elements. Key changes to improve health system functioning for complex heart failure patients that align with the CCM include closing knowledge gaps, standardizing treatment, improving interdisciplinary communication and improving patient care pathways following hospital discharge.</p><p><strong>Conclusions: </strong>The CCM can be used to guide health system design and interventions for frail and multi-morbid heart failure patients. Addressing care- and service-delivery barriers has important clinical, administrative and economic implications.</p>","PeriodicalId":92071,"journal":{"name":"Journal of comorbidity","volume":"10 ","pages":"2235042X20924172"},"PeriodicalIF":0.0,"publicationDate":"2020-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bf/b2/10.1177_2235042X20924172.PMC7303776.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38100046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-05-14eCollection Date: 2020-01-01DOI: 10.1177/2235042X20920456
Paul Edward Muckelt, E M Roos, M Stokes, S McDonough, D T Grønne, S Ewings, S T Skou
Objectives: Robust data on the impact of comorbidities on health in people with osteoarthritis (OA) are lacking, despite its potential importance for patient management. Objectives were to determine coexisting conditions in people with OA in primary care and whether more comorbidities were linked with individual health status. Methods: A retrospective analysis of 23,892 patients with knee and hip OA was conducted to determine comorbidities present (number/clusters) and how these linked with pain intensity (0–100), widespread pain (site numbers), medication usage (paracetamol, nonsteroidal anti-inflammatory drugs, opioids), quality of life EuroQol five dimension scale (EQ-5D), and physical function (walking speed) using independent t-tests or χ 2 test. Results: Sixty-two percent of people with OA treated in primary care had at least one comorbidity; hypertension (37%), heart disease (8%), and diabetes (7%) being most common. Outcome measures worsened with more comorbidities (0–4+ comorbidities); pain intensity [mean (SD)] 46(22)–57(21); number of painful sites 3.7(3.0)–6.3(5.4); quality of life 0.73(0.10)–0.63(0.15); walking speed 1.57 m/s (0.33)–1.24 m/s (0.31), while the proportion of people using pain medication increased from 0 to 2 comorbidities (58–69%; p < 0.001), with an increase in opioid use from 4.6% to 19.5% with more comorbidities (0–4+ comorbidities). Conclusion: Most people with knee or hip OA in primary care have at least one other long-term condition. A greater number of comorbidities is linked with worsening health, highlighting the importance of screening for comorbidities when treating patients with OA. It is important for clinicians to consider how OA treatments will interact and affect other common comorbidities.
目的:尽管合并症对患者管理具有潜在的重要性,但关于骨关节炎(OA)患者的合并症对健康影响的可靠数据尚缺乏。目的是确定初级保健中OA患者的共存状况,以及是否更多的合并症与个人健康状况有关。方法:采用独立t检验或χ 2检验,对23,892例膝关节和髋部OA患者进行回顾性分析,确定存在的合并症(数量/聚类)以及这些合并症与疼痛强度(0-100)、广泛疼痛(部位数量)、药物使用(扑热息痛、非甾体抗炎药、阿片类药物)、生活质量EuroQol五维量表(EQ-5D)和身体功能(步行速度)的关系。结果:62%接受初级保健治疗的OA患者至少有一种合并症;高血压(37%)、心脏病(8%)和糖尿病(7%)是最常见的。结果指标恶化,合并症更多(0-4+合并症);疼痛强度[平均(SD)] 46(22)-57(21);疼痛部位数3.7(3.0)-6.3(5.4);生活质量0.73(0.10)-0.63(0.15);步行速度1.57 m/s (0.33)-1.24 m/s(0.31),同时使用止痛药的人群合并症比例从0增加到2 (58-69%);P < 0.001),阿片类药物的使用从4.6%增加到19.5%,并伴有更多的合并症(0-4+合并症)。结论:大多数初级保健的膝关节或髋关节OA患者至少有一种其他长期疾病。更多的合并症与健康恶化有关,这突出了在治疗OA患者时筛查合并症的重要性。对于临床医生来说,重要的是要考虑OA治疗如何相互作用并影响其他常见的合并症。
{"title":"Comorbidities and their link with individual health status: A cross-sectional analysis of 23,892 people with knee and hip osteoarthritis from primary care.","authors":"Paul Edward Muckelt, E M Roos, M Stokes, S McDonough, D T Grønne, S Ewings, S T Skou","doi":"10.1177/2235042X20920456","DOIUrl":"https://doi.org/10.1177/2235042X20920456","url":null,"abstract":"Objectives: Robust data on the impact of comorbidities on health in people with osteoarthritis (OA) are lacking, despite its potential importance for patient management. Objectives were to determine coexisting conditions in people with OA in primary care and whether more comorbidities were linked with individual health status. Methods: A retrospective analysis of 23,892 patients with knee and hip OA was conducted to determine comorbidities present (number/clusters) and how these linked with pain intensity (0–100), widespread pain (site numbers), medication usage (paracetamol, nonsteroidal anti-inflammatory drugs, opioids), quality of life EuroQol five dimension scale (EQ-5D), and physical function (walking speed) using independent t-tests or χ 2 test. Results: Sixty-two percent of people with OA treated in primary care had at least one comorbidity; hypertension (37%), heart disease (8%), and diabetes (7%) being most common. Outcome measures worsened with more comorbidities (0–4+ comorbidities); pain intensity [mean (SD)] 46(22)–57(21); number of painful sites 3.7(3.0)–6.3(5.4); quality of life 0.73(0.10)–0.63(0.15); walking speed 1.57 m/s (0.33)–1.24 m/s (0.31), while the proportion of people using pain medication increased from 0 to 2 comorbidities (58–69%; p < 0.001), with an increase in opioid use from 4.6% to 19.5% with more comorbidities (0–4+ comorbidities). Conclusion: Most people with knee or hip OA in primary care have at least one other long-term condition. A greater number of comorbidities is linked with worsening health, highlighting the importance of screening for comorbidities when treating patients with OA. It is important for clinicians to consider how OA treatments will interact and affect other common comorbidities.","PeriodicalId":92071,"journal":{"name":"Journal of comorbidity","volume":"10 ","pages":"2235042X20920456"},"PeriodicalIF":0.0,"publicationDate":"2020-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/2235042X20920456","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38002709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}